G-CON launches their new cell therapy POD® design
The alarming rate of cancer pervasiveness around the world has caused the spike in demand for gene therapy treatment. According to Global Market Insights, the Cancer Gene Therapy Market size is expected to exceed $4.3 billion by 2024.
Our manufacturing partner, G-CON, recently announced the completion of a custom built cleanroom POD® system for Lonza, for their gene therapy manufacturing operation in Houston, TX.
Maik Jornitz, President and CEO of G-CON Manufacturing stated: “We committed to an aggressive timeframe for delivery and installation of the custom-built POD system because we knew of the importance of the timeline for Lonza in this cell therapy application, a major new area of drug development for Lonza as well as G-CON.”
Download this new presentation from G-CON which describes the features and benefits of their Cell Therapy POD designs. Click here to view or download G-CON’s Cell Therapy POD fact sheet. Contact STEQ America for more information.